Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Kansas Journal of Medicine
|
June 6, 2020
Clinical Outcomes of Intermediate-Length Cephalomedullary Nails for Intertrochanteric Femur Fracture Repair in Older Adults
Paul A Enns, Sue M Nyberg, Gina M Berg, et al.
Kansas Journal of Medicine
|
June 11, 2024
Influence of Bone Cement Augmentation on Complications in Cephalomedullary Nail Fixation of Geriatric Intertrochanteric Hip Fractures
Jake M Bianco, Nathan W Whitsell, Thomas J McCormack, et al.
Kansas Journal of Medicine
|
February 27, 2023
Improving Medical Student Mentorship in Orthopaedic Surgery
Seth A Tarrant, Vafa Behzadpour, Thomas J McCormack, et al.
Kansas Journal of Medicine
|
December 26, 2025
Improving Prophylactic Antibiotic Selection for Type 3 Open Fractures in the Trauma Setting
Matthew G Van Engen, Isaac C Talbert, William M Clune, et al.
Kansas Journal of Medicine
|
October 5, 2022
Clinical Rotation Handbook Promotes Orthopaedic Resident Wellness: A Quality Improvement Study
Joshua T Rogers, Faith Mi Ge Kim, Brayden J Strine, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2021
A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine
Chiara R Dart, Nabanita Mukherjee, Carol M Amato, et al.
The Journal of Investigative Dermatology
|
December 23, 2021
Expression Differences in BCL2 Family Members between Uveal and Cutaneous Melanomas Account for Varying Sensitivity to BH3 Mimetics
Nabanita Mukherjee, Chiara R Dart, Carol M Amato, et al.
Cancers
|
August 9, 2020
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma
Nabanita Mukherjee, Carol M Amato, Jenette Skees, et al.
Cell Death & Disease
|
June 10, 2020
MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells
Nabanita Mukherjee, Jenette Skees, Kaleb J Todd, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Kansas Journal of Medicine
|
June 6, 2020
Clinical Outcomes of Intermediate-Length Cephalomedullary Nails for Intertrochanteric Femur Fracture Repair in Older Adults
Paul A Enns, Sue M Nyberg, Gina M Berg, et al.
Kansas Journal of Medicine
|
June 11, 2024
Influence of Bone Cement Augmentation on Complications in Cephalomedullary Nail Fixation of Geriatric Intertrochanteric Hip Fractures
Jake M Bianco, Nathan W Whitsell, Thomas J McCormack, et al.
Kansas Journal of Medicine
|
February 27, 2023
Improving Medical Student Mentorship in Orthopaedic Surgery
Seth A Tarrant, Vafa Behzadpour, Thomas J McCormack, et al.
Kansas Journal of Medicine
|
December 26, 2025
Improving Prophylactic Antibiotic Selection for Type 3 Open Fractures in the Trauma Setting
Matthew G Van Engen, Isaac C Talbert, William M Clune, et al.
Kansas Journal of Medicine
|
October 5, 2022
Clinical Rotation Handbook Promotes Orthopaedic Resident Wellness: A Quality Improvement Study
Joshua T Rogers, Faith Mi Ge Kim, Brayden J Strine, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2021
A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine
Chiara R Dart, Nabanita Mukherjee, Carol M Amato, et al.
The Journal of Investigative Dermatology
|
December 23, 2021
Expression Differences in BCL2 Family Members between Uveal and Cutaneous Melanomas Account for Varying Sensitivity to BH3 Mimetics
Nabanita Mukherjee, Chiara R Dart, Carol M Amato, et al.
Cancers
|
August 9, 2020
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma
Nabanita Mukherjee, Carol M Amato, Jenette Skees, et al.
Cell Death & Disease
|
June 10, 2020
MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells
Nabanita Mukherjee, Jenette Skees, Kaleb J Todd, et al.
Page
of 4